CCIA
RETA

Campbell & Co Investment Adviser’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-9,400
Closed -$248K – 957
2021
Q4 		$248K Buy
+9,400
New +$248K 0.08% 442
2021
Q3 		– Sell
-3,800
Closed -$538K – 830
2021
Q2 		$538K Buy
+3,800
New +$538K 0.22% 132